Search Count: 28
 |
Sialic Acid Bound Form Of Tripartite Atp-Independent Periplasmic (Trap) Transporter From Fusobacterium Nucleatum.
Organism: Fusobacterium nucleatum, Vicugna pacos
Method: ELECTRON MICROSCOPY Release Date: 2024-12-11 Classification: MEMBRANE PROTEIN/IMMUNE SYSTEM |
Organism: Fusobacterium nucleatum, Vicugna pacos
Method: ELECTRON MICROSCOPY
Release Date: 2024-12-11
 |
Apo Form Of Tripartite Atp-Independent Periplasmic (Trap) Transporter From Fusobacterium Nucleatum.
Organism: Fusobacterium nucleatum, Vicugna pacos
Method: ELECTRON MICROSCOPY Release Date: 2024-12-11 Classification: MEMBRANE PROTEIN/IMMUNE SYSTEM |
Organism: Fusobacterium nucleatum, Vicugna pacos
Method: ELECTRON MICROSCOPY
Release Date: 2024-12-11
 |
Crystal Structure Of Antibody Scfv Against M2E Influenza Peptide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.75 Å Release Date: 2023-08-02 Classification: ANTIVIRAL PROTEIN Ligands: GOL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-08-02
Ligands: GOL
 |
Crystal Structure Of M2E Influenza Peptide In Complex With Antibody Scfv
Organism: Homo sapiens, Influenza a virus (a/new york/392/2004(h3n2))
Method: X-RAY DIFFRACTION Resolution:3.43 Å Release Date: 2023-08-02 Classification: ANTIVIRAL PROTEIN |
Organism: Homo sapiens, Influenza a virus (a/new york/392/2004(h3n2))
Method: X-RAY DIFFRACTION
Release Date: 2023-08-02
 |
Crystal Structure Of Antibody Scfv Against M2E Influenza Peptide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2023-08-02 Classification: ANTIVIRAL PROTEIN Ligands: FLC |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-08-02
Ligands: FLC
 |
Crystal Structure Of E.Coli Ccdb Mutant S12G
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2022-06-08 Classification: TOXIN Ligands: CL |
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION
Release Date: 2022-06-08
Ligands: CL
 |
Crystal Structure Of E.Coli Ccdb Mutant S60E
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2022-06-08 Classification: TOXIN Ligands: CL |
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION
Release Date: 2022-06-08
Ligands: CL
 |
Crystal Structure Of E.Coli Ccdb Mutant V46L
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION Resolution:1.35 Å Release Date: 2022-06-08 Classification: TOXIN Ligands: CL |
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION
Release Date: 2022-06-08
Ligands: CL
 |
Coiled-Coil Registry Shifts In The F684I Mutant Of Bicaudal D Result In Cargo-Independent Activation Of Dynein Motility
Organism: Drosophila melanogaster
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2020-05-13 Classification: MOTOR PROTEIN Ligands: CA |
Organism: Drosophila melanogaster
Method: X-RAY DIFFRACTION
Release Date: 2020-05-13
Ligands: CA
 |
Structure Of The C-Terminal Cargo Binding Domain Of Human Bicaudal D2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.01 Å Release Date: 2019-07-24 Classification: MOTOR PROTEIN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-07-24
 |
Proteus Mirabilis N-Acetylneuraminate Lyase
Organism: Proteus mirabilis (strain hi4320)
Method: X-RAY DIFFRACTION Resolution:1.56 Å Release Date: 2019-06-26 Classification: LYASE Ligands: SO4 |
Organism: Proteus mirabilis (strain hi4320)
Method: X-RAY DIFFRACTION
Release Date: 2019-06-26
Ligands: SO4
 |
2.1 A Resolution Structure Of Histamine Dehydrogenase From Rhizobium Sp. 4-9
Organism: Rhizobium sp. 4-9
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2019-05-15 Classification: OXIDOREDUCTASE Ligands: ADP, FMN, SF4, PO4 |
Organism: Rhizobium sp. 4-9
Method: X-RAY DIFFRACTION
Release Date: 2019-05-15
Ligands: ADP, FMN, SF4, PO4
 |
Crystal Structure Of Aldo-Keto Reductase 1C3 (Akr1C3) Complexed With Inhibitor.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2019-05-08 Classification: OXIDOREDUCTASE Ligands: NAP, FFW, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-05-08
Ligands: NAP, FFW, EDO
 |
Plasmodium Falciparum Dihydroorotate Dehydrogenase (Dhodh) Co-Crystallized With 3-Hydroxy-1-Methyl-5-((3-(Trifluoromethyl)Phenoxy)Methyl)-1H-Pyrazole-4-Carboxylic Acid
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2018-12-19 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, E2N |
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION
Release Date: 2018-12-19
Ligands: FMN, ORO, E2N
 |
Plasmodium Falciparum Dihydroorotate Dehydrogenase (Dhodh) Co-Crystallized With N-(2,2-Diphenylethyl)-4-Hydroxy-1,2,5-Thiadiazole-3-Carboxamide
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2018-12-19 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, DZB |
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION
Release Date: 2018-12-19
Ligands: FMN, ORO, DZB
 |
Targeting Myeloid Differentiation Using Potent Human Dihydroorotate Dehydrogenase (Hdhodh) Inhibitors Based On 2-Hydroxypyrazolo[1,5-A]Pyridine Scaffold
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.58 Å Release Date: 2018-07-11 Classification: OXIDOREDUCTASE Ligands: DUH, CL, FMN, ACT, ORO, GOL, PGE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-07-11
Ligands: DUH, CL, FMN, ACT, ORO, GOL, PGE
 |
Substrate-Bound Outward-Open State Of A Na+-Coupled Sialic Acid Symporter Reveals A Novel Na+-Site
Organism: Proteus mirabilis (strain hi4320)
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2018-04-04 Classification: MEMBRANE PROTEIN |
Organism: Proteus mirabilis (strain hi4320)
Method: X-RAY DIFFRACTION
Release Date: 2018-04-04
 |
Substrate-Bound Outward-Open State Of A Na+-Coupled Sialic Acid Symporter Reveals A Novel Na+-Site
Organism: Proteus mirabilis (strain hi4320)
Method: X-RAY DIFFRACTION Resolution:2.26 Å Release Date: 2018-04-04 Classification: MEMBRANE PROTEIN |
Organism: Proteus mirabilis (strain hi4320)
Method: X-RAY DIFFRACTION
Release Date: 2018-04-04
 |
Potent And Selective Aldo-Keto Reductase 1C3 (Akr1C3) Inhibitors Based On The Benzoisoxazole Moiety: Application Of A Bioisosteric Scaffold Hopping Approach To Flufenamic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2018-04-04 Classification: OXIDOREDUCTASE Ligands: NAP, CJ2 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-04-04
Ligands: NAP, CJ2
 |
Potent And Selective Aldo-Keto Reductase 1C3 (Akr1C3) Inhibitors Based On The Benzoisoxazole Moiety: Application Of A Bioisosteric Scaffold Hopping Approach To Flufenamic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2018-04-04 Classification: OXIDOREDUCTASE Ligands: CVN, CL, NAP |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-04-04
Ligands: CVN, CL, NAP